CRYL1 and cancer: Regarding the PER-CRY genes, the PER anticancer mechanism stems from inhibiting the phosphoinositide 3 kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway, which inhibits glycolysis in cancer cells, limiting their growth and resulting in arrest and apoptosis.